0 items USD 0.00Search
- Did you mean
- closing spondylitis
Your search for "Ankylosing spondylitis" gave back 103 results.
The global JAK1 Inhibitors market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of %...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Humira Biosimilar market size is expected to reach $ 955.4 million by 2029, rising at a market growth of 12.0% CAGR during the forecast...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Adalimumab Monoclonal Antibody Biosimilar market size is projected to grow from US$ 411.8 million in 2022 to US$ 966.9 million in 2029; it...
Catalog:
LPI
June 2023
Price: USD 3,660.00
An autoimmune disease is a condition arising from an abnormal immune response to a functioning body part. There are at least 80 types of autoimmune...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Diclofenac market size was valued at US$ million in 2023. With growing demand in downstream market, the Diclofenac is forecast to a...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Arthritic Therapeutic market size was valued at US$ 26650 million in 2023. With growing demand in downstream market, the Arthritic...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that is mainly employed to treat mild-to-moderate pain & reduces pain, inflammation...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global PDE 4 Inhibitors market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-...
Catalog:
GIR
August 2023
Price: USD 4,480.00
The global JAK1 Inhibitors market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-...
Catalog:
GIR
August 2023
Price: USD 4,480.00
The global Adalimumab Monoclonal Antibody Biosimilar market size is expected to reach $ 955.4 million by 2029, rising at a market growth of 12.0%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Humira Biosimilar market size was valued at USD 433.2 million in 2022 and is forecast to a readjusted size of USD 955.4 million by 2029...
Catalog:
GIR
June 2023
Price: USD 3,480.00
The global Adalimumab (Humira) and Biosimilar market size is projected to grow from US$ 21930 million in 2022 to US$ 14950 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
